SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001213900-24-042406
Filing Date
2024-05-13
Accepted
2024-05-13 17:14:38
Documents
11

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT ea0205761-01.htm POS AM 5761013
2 THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF OS THERAPIES INCORPOR ea020576101ex3-1_osthera.htm EX-3.1 55926
3 FORM OF CERTIFICATE OF AMENDMENT TO THE THIRD AMENDED AND RESTATED CERTIFICATE O ea020576101ex3-2_osthera.htm EX-3.2 11272
4 AMENDED AND RESTATED BYLAWS OF OS THERAPIES INCORPORATED ea020576101ex3-3_osthera.htm EX-3.3 126328
5 CONSENT OF MALONEBAILEY, LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea020576101ex23-1_osthera.htm EX-23.1 3466
6 GRAPHIC ex23-1_001.jpg GRAPHIC 22046
7 GRAPHIC ex23-1_002.jpg GRAPHIC 20706
8 GRAPHIC tos_logo.jpg GRAPHIC 85189
9 GRAPHIC timage_001.jpg GRAPHIC 331793
10 GRAPHIC timage_002.jpg GRAPHIC 340774
11 GRAPHIC tflowchart_001.jpg GRAPHIC 324455
  Complete submission text file 0001213900-24-042406.txt   7509470
Mailing Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850
Business Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850 410-297-7793
OS Therapies Inc (Filer) CIK: 0001795091 (see all company filings)

IRS No.: 825118368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-271034 | Film No.: 24940302
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)